Publications by authors named "Mitsuhiro Isaka"

Objectives: This study aimed to compare the quality of mediastinal lymph node dissection (LND) during lobectomy for clinical stage I-II non-small cell lung cancer (NSCLC) between video-assisted thoracic surgery (VATS) and open thoracotomy, using data from the Japan Clinical Oncology Group (JCOG) 1413 phase 3, randomized, controlled trial.

Methods: This analysis draws information from JCOG1413, comparing the efficacy of lobe-specific versus systematic LND with standardized LND protocols. A total of 1685 patients were included in this exploratory analysis (1251 VATSs and 434 open thoracotomies).

View Article and Find Full Text PDF

Objectives: TP53 is the most frequently mutated gene in non-small-cell lung cancer. Although TP53 co-mutation is associated with poor responses to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in advanced EGFR-mutated adenocarcinoma, its impact in resected early-stage lung adenocarcinoma remains unclear. In this study, we evaluated the effect of TP53 co-mutation on clinicopathological features, prognosis, and recurrence patterns in resected early-stage EGFR-mutated lung adenocarcinoma.

View Article and Find Full Text PDF

Introduction: Nodal staging of non-small cell lung cancer (NSCLC) is important for treatment decision-making. Comparative validation of various classifications based on anatomical location and station count, alone or in combination, remains lacking.

Methods: We analyzed 1,601 patients with pathological stage I-III disease undergoing complete resection between 2002 and 2019.

View Article and Find Full Text PDF

Quickly identifying driver gene mutations in solid cancers is important. However, next-generation sequencing (NGS)-based mutation detection methods are time-consuming and expensive. Peptide nucleic acid (PNA) probe-based mutant mRNA detection systems are quick and inexpensive.

View Article and Find Full Text PDF

Background: Thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is a high-grade malignant neoplasm with a poor prognosis. Most cases of SMARCA4-UT have extensive chest wall and mediastinum involvement. The efficacy of surgical resection has not been clearly established.

View Article and Find Full Text PDF
Article Synopsis
  • The JCOG0802/WJOG4607L trial showed segmentectomy is better than lobectomy for overall survival in small-peripheral non-small-cell lung cancer, but locoregional relapse (LR) is still a concern.
  • An analysis of 1105 patients with various tumor sites determined that factors like solid tumor appearance and close margins significantly increased the risk of LR after segmentectomy.
  • Key findings stress the importance of using thin-section CT scans and ensuring sufficient margin distance to minimize the risk of LR in patients undergoing segmentectomy.
View Article and Find Full Text PDF

Background: Mutations in the epidermal growth factor receptor (EGFR) gene are the most common targetable gene alterations in non-small cell lung cancer (NSCLC). In Japan, approximately 40% of patients who undergo surgical resection for non-squamous NSCLC have EGFR mutations. However, no long-term studies have been conducted including a large number of EGFR-positive NSCLC patients with postoperative recurrence (PR).

View Article and Find Full Text PDF

The perioperative treatments for non-small cell lung cancer (NSCLC) should control both local and microscopic systemic disease, because the survival of patients with NSCLC who underwent surgical resection alone has been dismal except in stage IA patients. One way to improve surgical outcome is the administration of chemotherapy before or after the surgical procedure. During the last two decades, many clinical studies have focused on developing optimal adjuvant or neoadjuvant cisplatin-based chemotherapy regimens that can be combined with surgical treatment and/or radiotherapy.

View Article and Find Full Text PDF
Article Synopsis
  • The Lung Cancer Surgical Study Group (LCSSG) of the Japan Clinical Oncology Group (JCOG), formed in 1986, has expanded from 26 to 52 institutions, involving various specialists in lung cancer treatment.
  • Initially focused on combined therapies, the group has shifted to studying surgical options for small-sized and peripheral non-small cell lung cancer since the 2000s, demonstrating the effectiveness of sublobar resection through clinical trials.
  • With advances in targeted therapies and the need for personalized medicine, the JCOG-LCSSG is adapting treatment strategies and conducting numerous clinical trials to enhance comprehensive care for lung cancer patients.
View Article and Find Full Text PDF

Pathological germline variants (PGVs) of RAD51D increase the risk of breast and ovarian cancer. In East Asia, c.270_271dup is the most frequently detected PGV of RAD51D; however, only a few cases have been reported in Japan.

View Article and Find Full Text PDF

Objective: The stair-climbing test (SCT) is used as a surrogate for cardiopulmonary exercise testing, which measures maximal oxygen uptake, and considered a useful method for assessing exercise capacity in thoracic surgery. This study aims to investigate whether the recovery time of percutaneous oxygen saturation (SpO) after stair climbing is a predictor of postoperative complications after lobectomy.

Methods: We retrospectively identified 54 patients who performed SCT and underwent lobectomy between January 2015 and February 2023 at Shizuoka Cancer Center.

View Article and Find Full Text PDF

Background: Although the positive rate of preresection pleural lavage cytology (PLC) is low, it is an important indicator of poor prognosis for non-small-cell lung cancer patients with frequent pleural dissemination (PD) recurrence. Thin-section computed tomography (TSCT) can reveal relationships between a primary tumor and the pleura at 1 to 2 mm intervals, and this is associated with visceral pleural invasion (VPI). However, its association with PLC remains unclear.

View Article and Find Full Text PDF

Background: In the treatment of nonsmall cell lung cancer (NSCLC), a disease-free survival of 5 years is a criterion for cure. This study aimed to evaluate the characteristics and outcomes of patients with brain metastases of NSCLC after a disease-free survival of 5 years (late recurrent brain metastasis [LRBM]).

Methods: We reviewed 1281 consecutive patients with brain metastasis of lung cancer at a single institute between November 2014 and December 2022.

View Article and Find Full Text PDF

Objectives: We investigated the incidence of late recurrence beyond 5 years after pulmonary resection and aimed to identify candidates for long-term surveillance.

Methods: We retrospectively reviewed the medical records of 978 non-small-cell lung cancer patients who underwent pulmonary resection between 2002 and 2015 and survived without recurrence for 5 years. Clinicopathological factors associated with recurrence-free survival beyond 5 years after surgery were investigated using univariate and multivariate analyses.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzes lymph node dissection (LND) during segmentectomy for small peripheral non-small cell lung cancer to determine the best practice for optimizing patient outcomes.
  • Among 1056 patients assessed, radiologic findings were the key factor linked to lymph node metastases (LNMs), with part-solid tumors having a significantly lower incidence of LNMs compared to pure-solid tumors.
  • The conclusions suggest selective LND is preferable for patients with pure-solid tumors, while nonadjacent interlobar and mediastinal LNDs are less impactful for those with part-solid tumors.
View Article and Find Full Text PDF
Article Synopsis
  • - Salivary gland-type tumors (SGTs) of the lung, which are rare and have a generally good prognosis, primarily include mucoepidermoid carcinoma (MEC) and adenoid cystic carcinoma (ACC), constituting over 90% of cases.
  • - Symptoms of bronchial obstruction like wheezing and shortness of breath typically lead to early diagnosis, with a reported 5-year survival rate of 63.4%.
  • - Treatment commonly involves surgical methods such as lobectomy or pneumonectomy, with lymphadenectomy recommended for patients with MEC, while advanced cases necessitate tailored therapies based on the tumor subtype.
View Article and Find Full Text PDF

Objectives: This study aimed to identify the risk factors for pulmonary functional deterioration after wedge resection for early-stage lung cancer with ground-glass opacity, which remain unclear, particularly in low-risk patients.

Methods: We analysed 237 patients who underwent wedge resection for peripheral early-stage lung cancer in JCOG0804/WJOG4507L, a phase III, single-arm confirmatory trial. The changes in forced expiratory volume in 1 s were calculated pre- and postoperatively, and a cutoff value of -10%, the previously reported reduction rate after lobectomy, was used to divide the patients into 2 groups: the severely reduced group (≤-10%) and normal group (>-10%).

View Article and Find Full Text PDF

Background: A methodology to assess the immune microenvironment (IME) of non-small cell lung cancer (NSCLC) has not been established, and the prognostic impact of IME factors is not yet clear.

Aims: This study aimed to assess the IME factors and evaluate their prognostic values.

Methods And Results: We assessed CD8 tumor-infiltrating lymphocyte (TIL) density, forkhead box protein P3 (Foxp3 ) TIL density, and programmed death receptor ligand-1 (PD-L1) tumor proportion score (TPS) using a machine-learning algorithm in whole-slide imaging (WSI).

View Article and Find Full Text PDF

The mutant allele frequency of the Pyruvate kinase (PK) gene has been investigated mostly in pure breed cats. We investigated the PK mutant gene in stray and animal hoarding mongrel cats in Hokkaido, Japan. We also investigated the kinship of individuals carrying the mutant gene.

View Article and Find Full Text PDF

Background: In the current tumor-node-metastasis (TNM) classification, the clinical T descriptor is defined by solid size (SS) on a computed tomography (CT) slice and the pathological one is done by invasive size (IS) in microscopic evaluations. We sometimes experience discrepancies in diagnosis of both descriptors. A volume analyzing application enables semi-automatic measurement of three-dimensional (3D) parameters in cases where there are discrepancies in diagnosing tumors' solid size and IS.

View Article and Find Full Text PDF

Objective: Positive pleural lavage cytology (PLC +) is a poor prognostic factor for non-small cell lung cancer (NSCLC). However, data on the impact of intraoperative rapid diagnosis of PLC (rPLC) are lacking. Therefore, we evaluated the efficacy of rPLC before resection during surgery.

View Article and Find Full Text PDF

The cranial cruciate ligament (CCL) rupture is a common orthopedic disease in dogs that is usually managed with tibial plateau leveling osteotomy (TPLO) or extracapsular lateral suture (ECLS). Osteotomy is generally associated with some complications, including nonunion. The periosteum plays an important role in bone growth and remodeling.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the safety and effectiveness of segmentectomy for patients with non-small-cell lung cancer (NSCLC) tumors up to 3 cm, particularly those with ground-glass opacity (GGO).
  • Conducted across 42 institutions in Japan, the trial involved 396 patients and focused on a primary endpoint of 5-year relapse-free survival (RFS), ultimately demonstrating a 98% RFS after a median follow-up of 5.4 years.
  • The findings suggest that segmentectomy could be a viable standard treatment option for NSCLC patients with GGO tumors 3 cm or smaller, with low rates of serious complications.
View Article and Find Full Text PDF

Background: Pulmonary vein stump thrombosis may occur after left upper lobectomy (LUL) and is a potential risk factor for cerebral infarction. However, there are few reports on the role of pulmonary vein stump thrombosis in the development of cerebral infarction. We aimed to clarify the correlation between pulmonary vein stump thrombosis and cerebral infarction following LUL.

View Article and Find Full Text PDF

Background: Pathological N2 (pN2) non-small cell lung cancer (NSCLC) is diverse; its treatment depends on the clinical N (cN) status. We aimed to determine the efficacy of upfront surgery for cN2pN2 NSCLC.

Methods: The study included 43 cN2pN2 NSCLC patients who underwent upfront surgery at the Shizuoka Cancer Center between 2002 and 2017.

View Article and Find Full Text PDF